Gliobastoma Multiforme

Survival in adult patients with low-grade brain tumors has improved

Survival in adult patients with low-grade brain tumors has improved

Outcomes for patients with low-grade gliomas have improved significantly in recent years, according to an analysis of clinical data collected from a US cancer registry over the past decade.

Bevacizumab-induced hypertension is a marker for improved outcomes in recurrent glioblastoma

Bevacizumab-induced hypertension is a marker for improved outcomes in recurrent glioblastoma

Researchers have found that bevacizumab-induced hypertension may be a predictive marker of improved outcomes in patients with recurrent glioblastoma who are treated with bevacizumab.

Virus plus rapamycin kills glioblastoma stem cells

By

An oncolytic virus infected and killed both brain cancer stem cells and differentiated compartments of the common and deadly malignant brain tumor, glioblastoma multiforme (GBM), when combined with the immunosuppressant drug rapamycin.

Therapeutic vaccine for brain cancer being studied

By

A vaccine for people newly diagnosed with glioblastoma multiforme—the most aggressive and highest-grade malignant glioma—is being tested at 20 sites nationwide in a phase II trial.

Portable glioblastoma treatment device receives approval

The FDA has approved a portable therapeutic system that can be used at home by adults who have glioblastoma that has recurred or progressed following chemotherapy and radiotherapy.

Carefully consider and monitor bevacizumab use

Using bevacizumab in combination with chemotherapy or biological therapy raises the risk of treatment-related death—but the agent's potential benefits may outweigh the relatively low absolute risk.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs